Protagonist Therapeutics CEO Dinesh V. Patel to Speak at Multiple Investment Bank Conferences in March 2026

Reuters
02/24
Protagonist <a href="https://laohu8.com/S/LENZ">Therapeutics</a> CEO Dinesh V. Patel to Speak at Multiple Investment Bank Conferences in March 2026

Protagonist Therapeutics Inc. said President and CEO Dinesh V. Patel will participate in multiple investment bank conferences in March 2026: TD Cowen 46th Annual Health Care Conference (fireside chat on March 3, 2026, 11:50 a.m. ET; webcast https://event.summitcast.com/view/9z5g2VrV6e6rbCqQgDRoHA/6QuKhqDYvNSrPH8co9v5gd), Leerink Global Healthcare Conference (fireside chat on March 9, 2026, 4:20 p.m. ET; webcast https://event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/K8FdPptAY5cyfndeY9RPP9), Jefferies Biotech on the Beach Summit (one-on-one meetings on March 10, 2026), Citizens Life Sciences Conference (fireside chat on March 11, 2026, 1:05 p.m. ET; webcast https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/UWj58vHDxUk6PseGJr4ebs), and Barclays 28th Annual Global Healthcare Conference (fireside chat on March 12, 2026, 11:30 a.m. ET; webcast https://cc.webcasts.com/barc002/031026a_js/?entity=30_ESKWJT8). Presentation replays will be available on the company’s Investor Relations Events and Presentations webpage: https://pr.report/iywa.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Protagonist Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202602240730ACCESSWRNAPR_____1140403) on February 24, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10